Phase 3 clinical trial of a novel oral benzimidazole riboside in transplant recipients with cytomegalovirus (CMV) infections that are refractory to available antiviral treatment

Type of Cancer
Unknown

Sponsor
Shire

Protocol Number
SHP620-303

To Learn More Call
(201)-510-0950